Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans

Jose Cortes-Briones1, Patrick D Skosnik2, Daniel Mathalon3

  • 11] Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT, USA [2] Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Insights

Cannabis disrupts human brain gamma-band oscillations, specifically at 40 Hz, and this disruption correlates with psychosis-like symptoms. These effects were less pronounced in recent cannabis users.

Area of Science:

  • Neuroscience
  • Psychopharmacology

Background:

  • Gamma (γ)-band oscillations are crucial for cognitive functions like perception and awareness.
  • Previous animal studies indicated cannabinoids disrupt γ-oscillations, but human data were lacking.

Purpose of the Study:

  • To investigate if cannabinoids disrupt γ-oscillations in humans.
  • To explore the relationship between these disruptions and psychosis-relevant behavioral effects.

Main Methods:

  • Twenty human participants received intravenous Δ-9-tetrahydrocannabinol (Δ(9)-THC) at placebo, 0.015, or 0.03 mg/kg doses.
  • Electroencephalography (EEG) recorded brain activity during auditory steady-state response (ASSR) at 20, 30, and 40 Hz.
  • Psychosis-relevant effects were assessed using the Positive and Negative Syndrome Scale (PANSS).

Main Results:

  • A high dose of Δ(9)-THC (0.03 mg/kg) significantly reduced 40 Hz intertrial coherence (ITC) compared to placebo.
  • A negative correlation was observed between 40 Hz ITC and PANSS scores, indicating a link to psychosis-related symptoms.
  • Δ(9)-THC showed a trend towards reducing evoked power at 40 Hz, with blunted effects in recent cannabis users.

Conclusions:

  • This study provides the first human evidence that cannabinoids disrupt γ-band neural oscillations.
  • The findings link cannabinoid-induced disruption of γ-oscillations to psychosis-relevant phenomena.
  • These results suggest a potential overlap between acute cannabinoid effects and alterations seen in psychotic disorders.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
1.0K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.6K